The Latest Breaking News from FDA

The U.S. Food and Drug Administration approved on Friday, the Novo Nordisk A/S (NYSE:NVO) Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years of age and older with hemophilia A or B without inhibitors.

Loomer's purge machine.

Justin Timberlake's health battle highlights the hidden symptoms of Lyme disease amid a sharp rise in 2025 US cases

Food manufacturers are masters of psychology, using clever language and design on their packaging to make products seem healthier than they are. This marketing technique, known as creating a “health halo,” tricks our brains into giving a food item a pass. We feel less guilty about consuming it, which often…

Loomer's latest victory.

Packaging mixup resulted in drinks labeled as Celsius energy drinks actually containing High Noon vodka seltzers

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake inhibitors, or SSRIs, in pregnancy.

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

A vodka seltzer mix-up in Celsius cans prompts an FDA-backed recall and legal scrutiny, raising concerns about branding, safety, and supply chain accountability.